Press Releases

Home > Press Releases

Press Releases (Page 176)

LifeLabs Scores Back-to-Back Win: Named 2024 BrandSpark Most Trusted for Second Consecutive Year

Toronto, Jan. 10, 2024 (GLOBE NEWSWIRE) -- LifeLabs is proud to announce our achievement for the second consecutive year – securing the 2024 BrandSpark Most Trusted Brand Award in Health Diagnostic Services. "In the ever-evolving landscape of healthcare, this back-to-back win is a testament to the unwavering commitment of our incredible team. It's not just an award; it's a promise we keep to our community—to be our customer's... ❯❯❯

Bicycle Health Publishes First-Ever Peer-Reviewed Research of Telehealth Treatment for Poppy Seed Tea Misuse

While poppy seeds are a legal substance, misuse of poppy seed tea can lead to opioid misuse, contribute to overdose and death Published in the Journal of Addictive Diseases, this first-of-its-kind study examined the effectiveness of using medication for opioid use disorder and telehealth treatment options for poppy seed tea use disorder BOSTON, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Bicycle Health, the nation’s largest virtual provider... ❯❯❯

Accanto Health appoints seasoned behavioral healthcare leader as CEO

Dr. Tom Britton will focus on driving growth and accessibility of treatment for people with eating disorders and related conditions using a compassionate, evidence-based approachST. PAUL, Minn., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Accanto Health, a national leader in eating disorder specialty care and behavioral health services, announced the appointment of veteran behavioral health executive Dr. Tom Britton as CEO this week. Accanto... ❯❯❯

Surgery Partners, Inc. Reaffirms 2023 Full Year Guidance and Provides 2024 Initial Adjusted EBITDA Outlook

BRENTWOOD, Tenn., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Members of management of Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, will be meeting with investors today, January 8, 2024, as part of the 42nd Annual J.P. Morgan Healthcare Conference, including a presentation at 5:15 p.m. ET. Based on results through November 2023, the Company is re-affirmin... ❯❯❯

Option Care Health Selects Palantir’s Artificial Intelligence Platform for Enterprise-Wide Digital Transformation

DENVER and BANNOCKBURN, Ill., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Palantir Technologies Inc. (NYSE: PLTR), a leading provider of AI systems, and Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent national provider of home and alternate site infusion services, today announced a multi-year commercial partnership for Palantir’s software to be leveraged across the company to help improve patient... ❯❯❯

RadNet, Inc. to Present at the 42nd Annual J.P. Morgan Healthcare Conference January 10th, 2024

LOS ANGELES, Jan. 08, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Dr. Howard Berger, President and Chief Executive Officer and Mark Stolper, Executive Vice President and Chief Financial Officer will be presenting at the 42nd Annual J.P. Morgan... ❯❯❯

Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms Guidance

CARLSBAD, Calif., Jan. 07, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announces select preliminary unaudited financial results for the full year ended December 31, 2023, and reaffirms its full-year 2023 financial guidance. Select Preliminary Unaudited Financial Results Record AVISE® CTD testing volume of approximately 137,000 units delivered during the year ended... ❯❯❯

Surgery Partners, Inc. to Present at Upcoming Investor Conference

BRENTWOOD, Tenn., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced that Eric Evans, Chief Executive Officer and Dave Doherty, Chief Financial Officer will meet with investors at the J.P. Morgan Healthcare Conference, including a presentation on Monday, January 8, 2024 at 5:15p.m. (Eastern Time). ... ❯❯❯

OnKure Announces IND Clearance by U.S. FDA Enabling Phase 1 Initiation for its Mutant Selective PI3Kα inhibitor, OKI-219

BOULDER, Colo., Jan. 04, 2024 (GLOBE NEWSWIRE) -- OnKure, Inc. today announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application of OKI-219, a potential best-in-class, mutant selective PI3Kα H1047R inhibitor, for clinical evaluation. H1047R is the most common mutation in PI3Kα, being found in 15% of breast cancer and 4% of cancers overall. There is a significant need for... ❯❯❯

Pennant and John Muir Health Enter into a Home Health Joint Venture in the Bay Area, California

EAGLE, Idaho, Jan. 02, 2024 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, today announced that it has closed on a home health joint venture with John Muir Health, a leading nonprofit integrated health system that serves communities throughout San Francisco’s East Bay Region. The closing of the joint venture... ❯❯❯